[English] 日本語
Yorodumi- PDB-9v36: Human DNMT1 (aa 698-1616) bound to hemimethylated dsDNA and Inhib... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9v36 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Human DNMT1 (aa 698-1616) bound to hemimethylated dsDNA and Inhibitor DMI26 | |||||||||||||||||||||
Components |
| |||||||||||||||||||||
Keywords | TRANSFERASE / DNA Methyltransferase 1 / DNA methylation inhibitor | |||||||||||||||||||||
| Function / homology | Function and homology informationhistone H3K23ub reader activity / negative regulation of phenotypic switching / histone H3K18ub reader activity / histone H3K14ub reader activity / negative regulation of vascular associated smooth muscle cell differentiation / chromosomal DNA methylation maintenance following DNA replication / negative regulation of vascular associated smooth muscle cell apoptotic process / DNA-methyltransferase activity / DNA (cytosine-5-)-methyltransferase / DNA (cytosine-5-)-methyltransferase activity ...histone H3K23ub reader activity / negative regulation of phenotypic switching / histone H3K18ub reader activity / histone H3K14ub reader activity / negative regulation of vascular associated smooth muscle cell differentiation / chromosomal DNA methylation maintenance following DNA replication / negative regulation of vascular associated smooth muscle cell apoptotic process / DNA-methyltransferase activity / DNA (cytosine-5-)-methyltransferase / DNA (cytosine-5-)-methyltransferase activity / STAT3 nuclear events downstream of ALK signaling / SUMOylation of DNA methylation proteins / methyl-CpG binding / DNA methylation-dependent constitutive heterochromatin formation / negative regulation of gene expression via chromosomal CpG island methylation / lncRNA binding / positive regulation of vascular associated smooth muscle cell proliferation / pericentric heterochromatin / heterochromatin / Nuclear events stimulated by ALK signaling in cancer / DNA methylation / PRC2 methylates histones and DNA / Defective pyroptosis / replication fork / promoter-specific chromatin binding / NoRC negatively regulates rRNA expression / chromosome / negative regulation of gene expression / positive regulation of gene expression / negative regulation of transcription by RNA polymerase II / mitochondrion / DNA binding / zinc ion binding / nucleoplasm / nucleus Similarity search - Function | |||||||||||||||||||||
| Biological species | Homo sapiens (human) | |||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.77 Å | |||||||||||||||||||||
Authors | Li, Z. | |||||||||||||||||||||
| Funding support | China, 1items
| |||||||||||||||||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2026Title: Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia. Authors: Shibing Tang / Liangyi Zong / Shuyuan Ma / Yini Shang / Jiale Wei / Jianguang Liu / Ying Cui / Huahui Guo / Kang Zou / Kezhi Wang / Hongkun Li / Fei Ye / Jing Huang / Cheng Luo / Zhihai Li / ...Authors: Shibing Tang / Liangyi Zong / Shuyuan Ma / Yini Shang / Jiale Wei / Jianguang Liu / Ying Cui / Huahui Guo / Kang Zou / Kezhi Wang / Hongkun Li / Fei Ye / Jing Huang / Cheng Luo / Zhihai Li / Stephen B Baylin / Xiangqian Kong / ![]() Abstract: Pharmacological reversal of abnormal promoter DNA hypermethylation at tumor suppressor genes (TSGs) is a key therapeutic paradigm for cancer management. However, the clinical efficacy of currently ...Pharmacological reversal of abnormal promoter DNA hypermethylation at tumor suppressor genes (TSGs) is a key therapeutic paradigm for cancer management. However, the clinical efficacy of currently approved nucleoside analog hypomethylating agents (HMAs) is limited by dose-dependent toxicity and high resistance rates. Nonnucleoside, DNA methyltransferase 1 (DNMT1)-selective inhibitors offer a promising alternative. To date, only limited chemotypes, exemplified by the dicyanopyridine derivative GSK3685032 (GSK5032), have demonstrated translatable DNMT1 inhibition, with resistance emerging upon prolonged exposure. To address these limitations, we employ structure-guided scaffold hopping and chemical optimization to develop a series of DNMT1 inhibitors (DNMT1i) featuring a bicyclic 7-azaindole scaffold. We identify DMI46, a potent enzymatic DNMT1i capable of reversing cancer-specific DNA methylation abnormalities and TSG silencing, leading to robust antileukemic effects and favorable tolerability. Cryoelectron microscopy (cryo-EM) studies reveal that the 7-azaindole inhibitor exhibits enhanced intercalation into hemi-methylated CpG dyads and increased minor-groove contacts within the DNMT1/hemimethylated DNA complex compared to GSK5032. These structural features enable sustained DNMT1 targeting and significant antiproliferative activity of DMI46 in GSK5032-resistant acute myeloid leukemia (AML) cells. We also demonstrate DMI46's capacity to overcome AML resistance to nucleoside-based HMAs both in vitro and in vivo. These findings introduce a distinct DNMT1i chemotype with enhanced on-target engagement and broad applicability against HMA-resistant AML. | |||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9v36.cif.gz | 178 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9v36.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 9v36.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/v3/9v36 ftp://data.pdbj.org/pub/pdb/validation_reports/v3/9v36 | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 64750MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Protein , 1 types, 1 molecules A
| #1: Protein | Mass: 103882.148 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: DNMT1, AIM, CXXC9, DNMT / Production host: ![]() References: UniProt: P26358, DNA (cytosine-5-)-methyltransferase |
|---|
-DNA chain , 2 types, 2 molecules BE
| #2: DNA chain | Mass: 3725.469 Da / Num. of mol.: 1 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) |
|---|---|
| #3: DNA chain | Mass: 3613.366 Da / Num. of mol.: 1 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) |
-Non-polymers , 3 types, 4 molecules 


| #4: Chemical | | #5: Chemical | ChemComp-SAH / | #6: Chemical | ChemComp-A1EQT / ( | Mass: 503.619 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C26H29N7O2S / Feature type: SUBJECT OF INVESTIGATION |
|---|
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | N |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: human DNMT1 bound to hemimethylated dsDNA and DMI26 / Type: COMPLEX / Entity ID: #1-#3 / Source: RECOMBINANT |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Source (recombinant) | Organism: ![]() |
| Buffer solution | pH: 7.4 |
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 3000 nm / Nominal defocus min: 1500 nm |
| Image recording | Electron dose: 72 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) |
-
Processing
| EM software | Name: PHENIX / Version: 1.14_3260 / Category: model refinement |
|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION |
| 3D reconstruction | Resolution: 2.77 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 394295 / Symmetry type: POINT |
| Refinement | Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) |
Movie
Controller
About Yorodumi



Homo sapiens (human)
China, 1items
Citation

PDBj









































FIELD EMISSION GUN